Original paper
Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota
Volume: 13, Issue: 39, Pages: 46406 - 46420
Published: Sep 27, 2021
Paper Details
Title
Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota
Published Date
Sep 27, 2021
Volume
13
Issue
39
Pages
46406 - 46420
Notes
History